Overview
- Eight children born through mitochondrial replacement therapy in the UK show no signs of inherited mitochondrial disease to date.
- New England Journal of Medicine data reveal reversion mutations of up to 16 percent in some treated embryos without immediate health effects.
- Only eight of 22 embryos generated via the procedure resulted in live births, indicating a success rate near 36 percent.
- The Human Fertilisation and Embryology Authority has imposed extended follow-up studies to assess potential long-term risks of germline mitochondrial modification.
- India’s ICMR and Department of Biotechnology are reviewing ethical and regulatory frameworks for mitochondrial donation as international interest mounts.